Pharmacology

The AIDS Clinical Trials Group (ACTG) established and supports the largest Network of expert clinical and translational investigators and therapeutic clinical trials units in the world, including sites in resource-limited countries. These investigators and units serve as the major resource for HIV/AIDS research, treatment, care, and training/education in their communities.

The UB-UZ HIV Research Training Program (HRTP) is supported by the NIH Fogarty International Center and is a postgraduate fellowship training initiative with an emphasis on HIV/AIDS clinical pharmacology between the University at Buffalo (UB) and the University of Zimbabwe (UZ). Program faculty at both institutions contribute mentored training to UZ students and scholars who, in turn, will contribute clinical pharmacology expertise to multidisciplinary teams to achieve the HIV/AIDS research goals for Zimbabwe.

The Clinical Pharmacology Quality Assurance (CPQA) is a cross-network program that develops and conducts quality assurance activities in support of HIV translational research and clinical trial networks. CPQA works with laboratories participating in HIV clinical trials to improve the quality of pharmacology data, increase awareness of the importance of pharmacology at clinical sites, and provide a mechanism for ensuring the quality of pharmacology data in HIV clinical trials.

The Drug Development Core brings together the expertise of Roswell Park Comprehensive Cancer Center (RPCCC) and the UB School of Pharmacy and Pharmaceutical Sciences to provide a resource (including training) in preclinical and early clinical development of novel compounds for investigators as part of the Clinical and Translational Science Institute (CTSI).

Mission: To provide leadership, services and infrastructure necessary to: establish multidisciplinary collaborations that achieve high-impact discoveries; support the early career development of diverse young HIV/AIDS investigators; and to establish a distinctive scientific identity, placing the University of Rochester and the University at Buffalo at the forefront of HIV/AIDS research.

The University of Rochester Medical Center has established a Center for Health + Technology (CHeT) whose mission is to conduct hypothesis-driven, rigorously designed, initial investigations of novel therapeutic interventions for human diseases.